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Synthesis of MDTF 1,3-dimethyl 2,2-bis(hydroxymethyl)propanedioate 1,3-dimethyl 2,2-bis(hydroxymethyl)propanedioate was synthesised according to the literature procedure. 
5,5-dimethyl 2,2-dimethyl-1,3-dioxane-5,5-dicarboxylate
To a solution of 1,3-dimethyl 2,2-bis(hydroxymethyl)propanedioate (1 eq., 20 g, 104 mmol) in 2,2-dimethoxypropane (90.3 mL) was added TsOH·H2O (10 %, 1.98 g, 10.4 mmol) at 25 °C. After the reaction mixture was maintained at room temperature for 1 h and was poured into a 5% (w/v) aqueous solution of NaHCO3 (70 mL) and toluene (100 mL). The resulting organic layer was washed with brine (100 mL) and evaporated to afford the desired 5,5-dimethyl 2,2-dimethyl-1,3-dioxane-5,5-dicarboxylate (22.7 g, 97.7 mmol, 94 %) as a transparent oil, which was used in the next step without purification.
1 H NMR (400MHz, CDCl3, δ ppm): 4.31 (s, 4 H), 3.79 (s, 6 H), 1.43 (s, 6 H).
13 C NMR (100MHz, CDCl3, δ ppm): 168.4, 98.6, 62.5, 53.8, 53.0, 23.5 .
MS(ESI) m/z: 232.09 [M+H]
+ .
methyl 2,2-dimethyl-1,3-dioxane-5-carboxylate
To a solution of 5,5-dimethyl 2,2-dimethyl-1,3-dioxane-5,5-dicarboxylate (1 eq., 21.4 g, 92.1 mmol) in DMSO (34 mL) were added LiCl (2 eq., 7.81 g, 184 mmol) and H2O (1 eq., 1.66 g, 1.66 mL, 92.1 mmol). The reaction mixture was heated to 160 °C and stirred for 2 h, then cooled to 0 °C.
To the reaction mixture were added water (120 mL) and EtOAc (240 mL), and the resulting mixture was filtered. To the filtrate was added EtOAc (40 mL), the organic layer was washed with brine (40mL) and concentrated carefully under reduced pressure (the product is volatile) to afford methyl 2,2-dimethyl-1,3-dioxane-5-carboxylate (10.8 g, 61.7 mmol, 67%), which was used in the next step without purification. Maleic anhydride (1 eq., 10 g, 101 mmol) and 2,2-diethoxyethylamine (1 eq., 13.6 g, 14.8 mL, 101 mmol) were stirred in acetone (75 mL) at room temperature overnight. The solvent was evaporated and the residue was recrystallized from propan-2-ol. The resulting product was treated with sodium acetate (1.2 eq., 10 g, 122 mmol) in acetic anhydride (100 mL). The reaction mixture was stirred for 1h at r.t., then for 2h at 90 0 C. After evaporation of acetic anhydride the residue was dissolved in EtOAc and filtered. The filtrate was concentrated in vacuo and the residue was purified by flash 5 chromatography (EtOAc/Cyclohexane gradient: 0/100 to 100/0) to give 1-(2,2-diethoxyethyl)-2,5-dihydro-1H-pyrrole-2,5-dione (15.2 g, 71.4 mmol, 70 %) as a yellow oil. A solution of 1 (1 eq., 2 g, 9.38 mmol), 2 (1 eq., 1.26 g, 9.38 mmol) and monohydrate of ptoluenesulfonic acid (0.2 eq., 0.357 g, 1.88 mmol) was refluxed in toluene (100 mL) and EtOH formed during the reaction was separated as the toluene azeotrope. After 2h the toluene was A solution of LiOH (4 eq., 0.526 g, 22 mmol) in H2O (10 mL) was added to a solution of 3 (1 eq.,
1.4 g, 5.49 mmol) in THF (20 mL) at rt. After stirring for 30min at r.t., EtOAc was added and the mixture was acidified to pH=2 with HCl. The mixture was extracted with EtOAc (3x), and the combined organic layer was washed with H2O and brine, dried over MgSO4 and concentrated to
give corresponding carboxylic acid (1.38 g, 5.33 mmol, 97 %) as a mixture of cis-and transisomers (4:6).
The mixture (1 eq., 1.38 g, 5.33 mmol) was treated with sodium acetate (2.4 eq., 1.05 g, 12.79 mmol) in acetic anhydride (20 mL). The reaction mixture was stirred 15 min at r.t. and then for 2h at 80°C. Acetic anhydride was evaporated and water (15 mL) was added to the mixture. The mixture was stirred for 30 min and extracted with EtOAc. The organic layer was washed with brine and dried over MgSO4. The solvent was evaporated and the residue was dissolved in a small amount of hot propan-2-ol and activated carbon was added. The resulting mixture was filtered off and the filtrate was kept at 0°C for 15 hours. The mixture was filtered, the precipitate was washed with cold propan-2-ol and dried to afford (2s,5s 
Conjugation with BHQ-2-thiol
To the solution of 6 (1 eq., 0.015 mmol, 300 μL, 50 mM in DMF) was added a solution of 4-((4-
mercaptoethyl)butanamide (BHQ-2-SH) (1 eq., 0.015 mmol, 300 μL, 50 mM in DMF) followed by the solution of triethylamine (3 eq., 0.045mmol, 45 μL, 1M in DMF). Table S1 . Normalized fluorescence of probes P1
and P2 after 12h and 72h in different media is shown in Table S2 . 1M HCl, pH=0 2% 5% 4% 5% Table S2 .Normalized fluorescence of MD-based (P1) and MCC-based (P2) probes (1μM) after 12h and 72h in different media at 37 °C.
Rate of succinimide hydrolysis of probe P1 in human plasma P1 and P2 FRET probes at 50µM (final concentration) were incubated in 2 mL of human plasma (DMSO 10%) at 37 ˚C. After defined intervals of time 100µL aliquots were mixed with 100µL of acetonitrile, allowing the precipitation of proteins, the resulting mixture was centrifuged and the 13 supernatant was analysed by HPLC. The conversion was calculated as the area under hydrolyzed product (hP1) divided by the total area. Preparation of antibody conjugates with DAR 8
Reduction of the antibody
Trastuzumab was dissolved in 10 mM PBS (pH 7.5) containing EDTA (2mM) to give 5 mg/mL solution. To this solution was added a solution of TCEP (4.8 eq., 100 mM in H2O). The mixture was incubated at 37°C for 2 h and used in the next without further purification.
Conjugation with cysteines
To 100 μL of the solution of the reduced trastuzumab was added the solution of 6 (30 eq., 4.13μL, 25 mM in DMF) or 7 (20 eq., 2.75μL, 25 mM in DMF) at 0 °C. The resulting mixture was incubated at 4 °C for 1h and then purified using Bio-Spin P-30 Columns (Bio-Rad, Hercules, U.S.A.) equilibrated with 10 mM PBS (pH 7.5). Conjugates were analyzed mass spectrometry.
A B Figure S . Deconvoluted mass spectra of the deglycosylated antibody conjugates. A. Conjugate with Dye-to-Antibody ratio (DAR) = 8.1 prepared using MD-TAMRA. B. Conjugate prepared using MCC-TAMRA with DAR = 8.3.
Characterization of conjugates
Prior to native MS experiments, antibody-dye conjugates (ADCs) were desalted against 150 mM ammonium acetate solution buffered at pH 7.4 using six cycles of concentration/dilution on microconcentrators (Vivaspin, 30 kD cutoff, Sartorius, Gottingen, Germany). Protein concentration was determined by UV absorbance using a NanoDrop spectrophotometer (Thermo Fisher Scientific, ions produced by a 2 mg/mL solution of cesium iodide in 2-propanol/water (1v/1v). Tuning parameters of the mass spectrometer were carefully optimized to improve desolvation and ion transfer as well as maintaining weak interactions. Particularly, the sample cone voltage Vc was set to 120 V and the backing pressure Pi was increased to 6 mbar to improve ion collisional cooling and maintain non-covalent interaction for averaging DAR calculation. Native MS data interpretation was performed using MassLynx 4.1 (Waters, Manchester, UK.).
Average DAR values from native MS were calculated from the relative peak intensities measured from the raw mass spectrum (taking into account 21 + to 26 + charge states). Average DAR value was obtained by summing up the weighted peak percentage from all observed species and dividing the sum by 100, as follows: DAR = Σ(relative peak intensity × number of loaded dye)/100 (number of dye load).
Stability of antibody-dye conjugates in human plasma
10µL of MD-based and MCC-based antibody dye conjugates (5mg/mL) were maintained in PBS buffer (10 mM, pH = 7,54) at 37 ˚C for 70h to achieve hydrolysis of succinimide ring, then diluted with 40uL of milli-Q water and 50µL of human plasma and incubated at 37 ˚C. Every 24h aliquots 
